BUSINESS

• Welireg Expected to Preserve Organ Function in VHL Disease: Urologist
  September 11, 2025

• Sobi Japan Targets Five Rare Diseases in Five Years, Says President
  September 10, 2025

• Teijin Pharma Bets on Ascendis Rare Disease Assets as Feburic Sales Crumble
  September 10, 2025

• Gilead Says It Has No Intention to Scrap License Deal: Carna Bio
  September 10, 2025

• Teikoku to Take Over Janssen’s Lopemin in Japan
  September 10, 2025

• Nippon Shinyaku’s EGPA Drug Bags Fast-Track Status in US
  September 10, 2025

• Lilly Japan Ramps Up Seishin Plant with New Building and Packaging Line
  September 9, 2025

• Janssen Files TAR-200 in Japan for High-Risk Bladder Cancer
  September 9, 2025

• Amicus CEO Confident on US$1 Billion Sales Target as Japan Pompe Launch Gets Underway
  September 9, 2025

• GSK Recalls 7 Lots of Omjjara in Japan over Quality Issue
  September 9, 2025

• Takeda Nabs Label Expansion for VWD Drug Vonvendi in US
  September 9, 2025

• Talvey Seen as Promising Option for Hard-to-Treat Multiple Myeloma: Oncologist
  September 8, 2025

• KM Biologics Developing Higher-Yield Liquid Immunoglobulin to Boost Efficiency and Supply
  September 8, 2025

• Susmed Wins Partial Change Approval for Insomnia App, Seeks Coverage
  September 8, 2025

• Ferring Files for Japan Approval of Bladder Cancer Gene Therapy
  September 8, 2025

• Kaken’s Onychomycosis Drug Grabs German Approval
  September 8, 2025

• Japan Ethical Drug Sales Inch Up 0.7% in July: Crecon
  September 8, 2025

• Nichi-Iko Shows Signs of Recovery but Restructuring Still Underway: CEO
  September 5, 2025

• And Pharma Chief Pledges Growth Strategy as New Generics Holding Firm Takes Shape
  September 5, 2025

• New Study of Vasomune-Partnered AV-001 Cleared in Canada: AnGes
  September 5, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 35
• 36
• 37
• 38
• 39
• 40
• 41
• 42
• 43
• …
• Next ›
• 最終 »